PIK3CG and gastric cancer: CMG002 (Figure 7, 41) as a newly developed PI3K/mTOR dual inhibitor effectively induces gastric cancer cell death when combined with CQ by inducing the G0/G1 cell cycle arrest and enhancing apoptotic cell death in AGS and NUGC3 cells (Kim et al., 2019).